Quarterly report pursuant to Section 13 or 15(d)

Consolidated Interim Consolidated Balance Sheets

v3.10.0.1
Consolidated Interim Consolidated Balance Sheets - USD ($)
May 31, 2018
Nov. 30, 2017
CURRENT    
Cash and cash equivalents $ 918,801 $ 1,965,043
Accounts receivable 130,043 36,412
Inventory 179,151 157,303
Prepaid expenses and other receivables 138,870 6,648
Total Current Assets 1,366,865 2,165,406
Patents 110,000 0
Property and equipment 31,329 26,951
TOTAL ASSETS 1,508,194 2,192,357
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 285,867 393,341
Unsecured convertible debentures 0 40,357
Derivative liabilities 596,635 539,860
Total Current Liabilities 882,502 973,558
Long term secured convertible debentures 943,261 892,176
Total Liabilities 1,825,763 1,865,734
Capital stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (November 30, 2017 - nil). 0 0
Common stock, $0.001 par value 200,000,000 shares authorized (2017: 200,000,000), 94,195,208 issued and outstanding (November 30, 2017: 93,014,134) 94,195 93,014
Additional paid-in capital 31,561,998 31,365,097
Deficiency (31,938,885) (31,098,864)
Accumulated Other Comprehensive Loss (34,877) (32,624)
Total Stockholders' (Deficiency) Equity (317,569) 326,623
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIENCY) EQUITY $ 1,508,194 $ 2,192,357